Endocrine tumours and neoplasia

ea0056p110 | Endocrine tumours and neoplasia

Ectopic adrenocorticotropic hormone syndrome: clinical features, diagnosis, treatment and long-term observation. Impact of bronchial carcinoid tumors

ea0056p111 | Endocrine tumours and neoplasia

Effect of ¹⁷⁷Lu-dotatate on severe, life-threatening, and refractory hypoglycemia associated with malignant insulinoma

ea0056p112 | Endocrine tumours and neoplasia

Morphological changes of the adrenal glands with hypertension with a crisis current

ea0056p113 | Endocrine tumours and neoplasia

Atypical manifestation of adrenocortical carcinoma – case series

ea0056p114 | Endocrine tumours and neoplasia

Are there any clinical predictor for malignancy in malignant pheochromocytoma?

ea0056p115 | Endocrine tumours and neoplasia

New cancer drug targets identified in adrenocortical carcinoma through gene expression profiling

ea0056p116 | Endocrine tumours and neoplasia

Outcome of adjuvant mitotane therapy in patients with adrenocortical carcinoma: the experience of San Luigi Gonzaga Hospital

ea0056p117 | Endocrine tumours and neoplasia

Adrenocortical carcinoma – characteristics and outcome of patients treated at Helsinki University Hospital during the last 15 years

ea0056p118 | Endocrine tumours and neoplasia

Comparative study between familial and sporadic pheochromocytoma

ea0056p119 | Endocrine tumours and neoplasia

Clinical features, management and outcomes of adrenocortical carcinoma: a case series analysis

ea0056p120 | Endocrine tumours and neoplasia

A case of multiple endocrine neoplasia type 1 (MEN1) with non-insulinoma pancreatogenous hypoglycemia syndrome (NIPHS) responding to medical treatment with diazoxide

ea0056p121 | Endocrine tumours and neoplasia

A case of benign insulinoma successfully treated with endoscopic ultrasound guided radiofrequency ablation

ea0056p122 | Endocrine tumours and neoplasia

Careful selection of patients with primary aldosteronism using combination of age, serum potassium and CT adrenal glands can avoid the need for adrenal venous sampling prior to adrenalectomy.

ea0056p123 | Endocrine tumours and neoplasia

Hormonal secretion prevalence in a series of subjects with adrenal tumors incidentally discovered in clinical practice

ea0056p124 | Endocrine tumours and neoplasia

Genetic background as a predictive factor of pheochromocytoma and paraganglioma presentation

ea0056p125 | Endocrine tumours and neoplasia

Heterogeneous genetic background of Hungarian patients with pheochromocytoma/paraganglioma requires gene panel testing

ea0056p126 | Endocrine tumours and neoplasia

Gastroenteropancreatic neuroendocrine tumors are predictive for a positive MEN1 germline mutation test: evidence from Hungarian MEN1 cohort

ea0056p127 | Endocrine tumours and neoplasia

Adrenocortical cancer – the effectiveness of mitotane therapy depending on the time of therapy and the therapeutic dose

ea0056p128 | Endocrine tumours and neoplasia

Ghrelin is overexpressed in adrenal cancers and stimulates proliferation and migration of ACC cell line.

ea0056p129 | Endocrine tumours and neoplasia

The effect of temozolomide on pancreatic neuroendocrine tumours and role of MGMT and MMR system in temozolomide resistance

ea0056p130 | Endocrine tumours and neoplasia

Treatment with (177Lu)-dotatate in patients with advanced metastatic somatostatin receptor-positive tumors

ea0056p131 | Endocrine tumours and neoplasia

Severe impairments in health-related quality of life in patients with small intestine neuroendocrine tumors

ea0056p132 | Endocrine tumours and neoplasia

Role of GLUT-2 expression and MGMT methylation for streptozotocin clinical response in adrenocortical carcinoma

ea0056p133 | Endocrine tumours and neoplasia

Presence and functional role of KiSS/KiSS-R system in pancreatic neuroendocrine tumors (panNETs) and its relationship with clinical features and tumor behavior

ea0056p134 | Endocrine tumours and neoplasia

Mesenchymal tissue markers as potential drug targets in adrenocortical tumours

ea0056p135 | Endocrine tumours and neoplasia

Multiple endocrine neoplasia type 1: a retrospective monocenter analysis of 73 cases

ea0056p136 | Endocrine tumours and neoplasia

Cell line derived from glioblastoma synthesizes steroid hormone. Effect of enzyme inhibitors

ea0056p137 | Endocrine tumours and neoplasia

Unraveling the incidence and clinical patterns of neuroendocrine neoplasms in Greece, through the experience of multipotent, specialized clinical centers.

ea0056p138 | Endocrine tumours and neoplasia

Evaluation of neurofibromatosis type 1 and gastroenteropancreatic neuroendocrine tumors.

ea0056p139 | Endocrine tumours and neoplasia

Prevalence of undiagnosed Medullary Thyroid Carcinoma and Phaeochromocytoma in MEN2A syndrome revealed by cascade screening

ea0056p140 | Endocrine tumours and neoplasia

Achievement of therapeutic mitotane concentrations in management of advanced adrenocortical cancer: a single centre experience in 47 patients

ea0056p141 | Endocrine tumours and neoplasia

Patients with metastatic bone disease and neuroendocrine neoplasms: the experience of a multi-center study

ea0056p142 | Endocrine tumours and neoplasia

Clinical features of ‘dedifferentiation’ in advanced pancreatic neuroendocrine neoplasms: the experience of two centers of excellence

ea0056p143 | Endocrine tumours and neoplasia

Endocrine Abstracts

20th European Congress of Endocrinology

Poster Presentations: Adrenal and Neuroendocrine Tumours

Ectopic adrenocorticotropic hormone syndrome: clinical features, diagnosis, treatment and long-term observation. Impact of bronchial carcinoid tumors

Effect of ¹⁷⁷Lu-dotatate on severe, life-threatening, and refractory hypoglycemia associated with malignant insulinoma

Morphological changes of the adrenal glands with hypertension with a crisis current

Atypical manifestation of adrenocortical carcinoma – case series

Are there any clinical predictor for malignancy in malignant pheochromocytoma?

New cancer drug targets identified in adrenocortical carcinoma through gene expression profiling

Outcome of adjuvant mitotane therapy in patients with adrenocortical carcinoma: the experience of San Luigi Gonzaga Hospital

Adrenocortical carcinoma – characteristics and outcome of patients treated at Helsinki University Hospital during the last 15 years

Comparative study between familial and sporadic pheochromocytoma

Clinical features, management and outcomes of adrenocortical carcinoma: a case series analysis

A case of multiple endocrine neoplasia type 1 (MEN1) with non-insulinoma pancreatogenous hypoglycemia syndrome (NIPHS) responding to medical treatment with diazoxide

A case of benign insulinoma successfully treated with endoscopic ultrasound guided radiofrequency ablation

Careful selection of patients with primary aldosteronism using combination of age, serum potassium and CT adrenal glands can avoid the need for adrenal venous sampling prior to adrenalectomy.

Hormonal secretion prevalence in a series of subjects with adrenal tumors incidentally discovered in clinical practice

Genetic background as a predictive factor of pheochromocytoma and paraganglioma presentation

Heterogeneous genetic background of Hungarian patients with pheochromocytoma/paraganglioma requires gene panel testing

Gastroenteropancreatic neuroendocrine tumors are predictive for a positive MEN1 germline mutation test: evidence from Hungarian MEN1 cohort

Adrenocortical cancer – the effectiveness of mitotane therapy depending on the time of therapy and the therapeutic dose

Ghrelin is overexpressed in adrenal cancers and stimulates proliferation and migration of ACC cell line.

The effect of temozolomide on pancreatic neuroendocrine tumours and role of MGMT and MMR system in temozolomide resistance

Treatment with (177Lu)-dotatate in patients with advanced metastatic somatostatin receptor-positive tumors

Severe impairments in health-related quality of life in patients with small intestine neuroendocrine tumors

Role of GLUT-2 expression and MGMT methylation for streptozotocin clinical response in adrenocortical carcinoma

Presence and functional role of KiSS/KiSS-R system in pancreatic neuroendocrine tumors (panNETs) and its relationship with clinical features and tumor behavior

Mesenchymal tissue markers as potential drug targets in adrenocortical tumours

Multiple endocrine neoplasia type 1: a retrospective monocenter analysis of 73 cases

Cell line derived from glioblastoma synthesizes steroid hormone. Effect of enzyme inhibitors

Unraveling the incidence and clinical patterns of neuroendocrine neoplasms in Greece, through the experience of multipotent, specialized clinical centers.

Evaluation of neurofibromatosis type 1 and gastroenteropancreatic neuroendocrine tumors.

Prevalence of undiagnosed Medullary Thyroid Carcinoma and Phaeochromocytoma in MEN2A syndrome revealed by cascade screening

Achievement of therapeutic mitotane concentrations in management of advanced adrenocortical cancer: a single centre experience in 47 patients

Patients with metastatic bone disease and neuroendocrine neoplasms: the experience of a multi-center study

Clinical features of ‘dedifferentiation’ in advanced pancreatic neuroendocrine neoplasms: the experience of two centers of excellence

Clinical features of a gastric neuroendocrine neoplasms type 1 series

BiosciAbstracts